Annual ROA
-109.34%
-45.14%-70.31%
December 31, 2023
Summary
- As of February 8, 2025, CMMB annual return on assets is -109.34%, with the most recent change of -45.14% (-70.31%) on December 31, 2023.
- During the last 3 years, CMMB annual ROA has fallen by -61.64% (-129.22%).
- CMMB annual ROA is now -463.90% below its all-time high of -19.39%, reached on December 31, 2021.
Performance
CMMB ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-76.18%
+6.06%+7.37%
September 1, 2024
Summary
- As of February 8, 2025, CMMB quarterly return on assets is -76.18%, with the most recent change of +6.06% (+7.37%) on September 1, 2024.
- Over the past year, CMMB quarterly ROA has increased by +6.06% (+7.37%).
- CMMB quarterly ROA is now -375.23% below its all-time high of -16.03%, reached on June 30, 2021.
Performance
CMMB Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
CMMB ROA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -70.3% | +7.4% |
3 y3 years | -129.2% | +7.4% |
5 y5 years | -129.2% | +7.4% |
CMMB ROA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -463.9% | at low | -300.5% | +9.8% |
5 y | 5-year | -463.9% | at low | -375.2% | +9.8% |
alltime | all time | -463.9% | at low | -375.2% | +9.8% |
Chemomab Therapeutics ROA History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -76.18%(-7.4%) |
Jun 2024 | - | -82.24%(-2.2%) |
Mar 2024 | - | -84.06%(-0.5%) |
Dec 2023 | -109.34%(+70.3%) | -84.48%(+3.6%) |
Sep 2023 | - | -81.58%(-3.1%) |
Jun 2023 | - | -84.19%(+24.2%) |
Mar 2023 | - | -67.78%(+29.1%) |
Dec 2022 | -64.20% | -52.51%(+24.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | -42.10%(+35.9%) |
Jun 2022 | - | -30.98%(+28.4%) |
Mar 2022 | - | -24.12%(+26.8%) |
Dec 2021 | -19.39%(-59.4%) | -19.02%(+6.6%) |
Sep 2021 | - | -17.84%(+11.3%) |
Jun 2021 | - | -16.03%(-2.4%) |
Mar 2021 | - | -16.42%(-65.6%) |
Dec 2020 | -47.70% | -47.70% |
FAQ
- What is Chemomab Therapeutics annual return on assets?
- What is the all time high annual ROA for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual ROA year-on-year change?
- What is Chemomab Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly ROA year-on-year change?
What is Chemomab Therapeutics annual return on assets?
The current annual ROA of CMMB is -109.34%
What is the all time high annual ROA for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual return on assets is -19.39%
What is Chemomab Therapeutics annual ROA year-on-year change?
Over the past year, CMMB annual return on assets has changed by -45.14% (-70.31%)
What is Chemomab Therapeutics quarterly return on assets?
The current quarterly ROA of CMMB is -76.18%
What is the all time high quarterly ROA for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly return on assets is -16.03%
What is Chemomab Therapeutics quarterly ROA year-on-year change?
Over the past year, CMMB quarterly return on assets has changed by +6.06% (+7.37%)